NAM-Driven 3D Cell Culture Innovation

by Tebubio

6 months ago
New Approach Methodologies (NAMs), 3D cell culture technologies

These innovative in vitro models offer greater physiological relevance than conventional 2D cultures, enabling more predictive studies of disease mechanisms, drug responses and cellular behaviour, whi...

iPSC Models from Diseased Donors

by Tebubio

6 months ago
iPSC Models

These models provide direct access to patient-relevant human cell types, including cortical neurons, dopaminergic neurons, astrocytes, and motor neurons, from donors carrying disease-specific genetic ...

High-Performance Tools for Ubiquitination and Degradation Pathways

by Tebubio

7 months ago
Ubiquitination, TUBEs

From cancer research to neurodegenerative diseases, their partner, LifeSensors offers a wide range of technologies for ubiquitination, targeted protein degradation (TPD), PROTACs, molecular glues and ...

Tebubio Partners with 4Dcell to Expand Access to Advanced 3D Cell Culture, 'NAMs', Technologies

by Tebubio

7 months ago
SmartSPhero, 4DCell, Tebubio

Tebubio, a European distributor of life science research reagents and services, partners with 4Dcell, a pioneering company specializing in the design of innovative cell culture environments. This coll...

Tebubio and Apricell Announce Partnership to Advance 3D Cell Culture and Organoid Research

by Tebubio

7 months ago
Tebubio, Apricell, 3D Cell Culture, Organoid Research

A new partnership has been established between Tebubio, a leading distributor of life science research reagents and services, and Apricell, an innovative company specializing in 3D cell culture techno...

What Role is Precision Medicine Playing in Transforming Cancer Treatment, and How Are Developers Adapting?

by Tebubio

9 months ago
Precision Medicine, CRISPR and mRNA

Precision medicine is redefining oncology by moving away from “one-size-fits-all” treatments towards therapies tailored to the unique genetic and molecular profile of each patient.

Push the boundaries of pre-clinical cancer research with CJ215

by Tebubio

9 months ago
CJ215

When your imaging must be precise and reliable, CJ215 delivers. This next-generation tumour-labelling dye is validated across multiple models ; breast, pancreatic, prostate, colon and fibrosarcoma ; s...

aberrior & Tebubio: Joined Forces to Expand Access to Fluorescent Probes in Europe

by Tebubio

11 months ago
Fluorescent Probes, aberrior & Tebubio

Tebubio colabora ahora con abberior. Esta colaboración facilita el acceso a colorantes brillantes y fotoestables a los investigadores en ciencias de la vida y microscopía avanzada.

The RNA Revolution – Strategic Partnerships Driving the Future of Vaccine Development

by Tebubio

11 months ago
RNA Revolution

In the RNA field, many companies are facing challenges when advancing research projects due to time, expertise, and resource constraints. Many biotechnology firms are seeking to overcome these hurdles...